Valuation: Carvolix

Market Cap 366M 328M 303M 275M 512M 34.83B 519M 3.62B 1.44B 18.23B 1.37B 1.34B 57.72B P/E 2026 *
-12.1x
P/E 2027 * -12.1x
Enterprise Value 401M 359M 332M 301M 561M 38.16B 568M 3.97B 1.58B 19.97B 1.5B 1.47B 63.24B EV / Sales 2026 *
280x
EV / Sales 2027 * 11.6x
Free-Float
16.12%
Yield 2026 *
-
Yield 2027 * -
1 day+0.36%
1 week-3.82%
Current month-4.15%
1 month-1.77%
3 months-1.07%
6 months+87.80%
Current year+220.23%
1 week 5.36
Extreme 5.36
6.08
1 month 4.92
Extreme 4.92
6.08
Current year 1.73
Extreme 1.73
7.56
1 year 1.33
Extreme 1.33
7.56
3 years 1.16
Extreme 1.16
7.56
5 years 0.93
Extreme 0.93
7.56
10 years 0.93
Extreme 0.93
8.6
Date Insider Type Main position Quantity % Market Cap. Importance
24/10/25
Truffle Capital SAS
BuyCompany 16,176 0.0411%
27/09/25
Truffle Capital SAS
BuyCompany 18,382 0.0467%
06/02/24
Truffle Capital SAS
BuyCompany 1,419,871 4.5955%
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%-3.82%+295.71%+346.77% 364M
-0.45%+0.19%-19.30%+10.54% 178B
+0.86%-0.13%-20.78%+16.07% 116B
+0.88%+0.16%+0.69%+36.51% 115B
-2.26%+18.07%-43.85%+5.76% 93.1B
-0.31%-5.51%-3.48%+72.86% 62.09B
+0.17%+1.64%+8.50%+82.24% 55.87B
+0.07%+0.70%+4.34%-22.43% 53.12B
+0.30%+0.89%-13.05%+43.83% 44.22B
+0.10%+3.37%-4.73%-8.71% 33.59B
Average -0.03%+1.63%+20.41%+58.34% 75.14B
Weighted average by Cap. -0.11%+2.37%-13.29%+24.19%

Financials

2026 *2027 *
Net sales 1.43M 1.28M 1.19M 1.07M 2M 136M 2.03M 14.18M 5.65M 71.36M 5.37M 5.26M 226M 37.35M 33.49M 30.93M 28.03M 52.25M 3.56B 52.97M 370M 147M 1.86B 140M 137M 5.89B
Net income -37.59M -33.69M -31.12M -28.21M -52.57M -3.58B -53.3M -372M -148M -1.87B -141M -138M -5.93B -11.54M -10.35M -9.55M -8.66M -16.14M -1.1B -16.37M -114M -45.54M -575M -43.29M -42.39M -1.82B
Net Debt 35.01M 31.39M 28.99M 26.28M 48.97M 3.33B 49.65M 347M 138M 1.74B 131M 129M 5.52B 68.99M 61.84M 57.11M 51.77M 96.49M 6.57B 97.83M 683M 272M 3.44B 259M 253M 10.88B
Projected Income Statement - Annual - Carvolix
Logo Carvolix
Carvolix (formerly Affluent Medical) specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
Employees
102
Date Price Change Volume
28/10/26 €5.540 +0.36% 13,245
27/10/26 €5.520 -6.12% 40,218
26/10/26 €5.880 +1.73% 29,181
23/10/26 €5.780 -2.69% 6,634
22/10/26 €5.940 +0.34% 15,136
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Carvolix
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
5.540EUR
Average target price
8.775EUR
Spread / Average Target
+58.39%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Carvolix